OCT 10, 2018 10:30 AM PDT

Microbiome Signatures in Gynecologic Cancers

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Consultant, Department of Surgery & Department of Obstetrics & Gynecology, Assistant Professor, Microbiome Program, Center for Individualized Medicine, Mayo Clinic
    Biography
      Marina Walther-Antonio, PhD is an Associate Consultant in the Department of Surgery and Department of Obstetrics and Gynecology and an Assistant Professor in the Microbiome Program at Mayo Clinic. She leads an interdisciplinary research program that studies the role of the human microbiome in women's health, and in gynecologic cancers in particular. In order to achieve this, Dr. Walther-Antonio and her research team have characterized the female reproductive tract microbiome in benign gynecologic conditions, cancer precursors, and endometrial and ovarian cancer manifestation. Their efforts have resulted in the identification of microbiota markers for endometrial cancer and in the development of translational approaches towards early detection and prevention of the disease. The ultimate goal is to pinpoint intervention opportunities that are amenable to modification of disease risk or can diminish the use of aggressive therapeutic options. Dr. Walther-Antonio's ovarian cancer research is concentrated on the search for an early detection microbiome biomarker and mechanistic role in response to therapy involving monitoring during a clinical trial and patient derived xenograft mouse model. Because mechanistic microbiome studies benefit from complex host/microbe interrogation with a cellular level of resolution, the research team is also focused on the development and application of single-cell microfluidic technologies, such as Optofluidics and Digital Microfluidics.

    Abstract

    The microbiome signatures in the context of gynecologic cancers (endometrial and ovarian) and the potential for their clinical use will be discussed. The use of microfluidic technologies to interrogate the role of these microbes in the disease processes and interference with treatment will also be addressed.

    Learning Objectives:

    1. Learn how the vaginal microbiome can be used to detect endometrial cancer
    2. Study ovarian cancer microbiome use as a prognostic tool
    3. Explore the use of microfluidic technologies for a single cell level of mechanistic interrogation for the role of the microbiome in gynecologic cancers 


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    Loading Comments...
    Show Resources
    Attendees
    • See more